首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1512651

全球自動化血液分析儀市場 - 2024-2031

Global automated hematology analyzer Market - 2024-2031

出版日期: 2024年07月10日 | 出版商:

DataM Intelligence | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球自動化血液分析儀市場規模達到4.56億美元，預計2031年將達到7.95億美元，2024-2031年預測期間複合年成長率為7.2%。

自動血液分析儀是一種高度專業化的電腦化機器，可計算血液樣本中不同類型的紅血球和白血球、血小板、血紅素和血球容積比水平的數量。

它們包括可編程自動警報系統，用於指示超出參考範圍的結果。血液分析儀涉及疾病的檢測、監測、預後和後續篩檢，廣泛應用於血友病、血癌、血栓等各種血液相關疾病。其他疾病包括白血病、貧血、輸血、惡性淋巴瘤以及其他需要血液學診斷的疾病。

該市場受到血液疾病盛行率上升、技術進步以及自動化血液學儀器採用率上升等因素的推動。

市場動態：

司機

血液疾病盛行率上升

全球自動化血液分析儀市場的需求是由多種因素所驅動的。主要因素之一是血液疾病發生率的增加推動了市場的成長。澳洲政府衛生和老年護理部2022年12月報告稱，每年約有33萬名受影響的嬰兒出生，其中83%患有鐮狀細胞疾病，17%患有地中海貧血，7%的準媽媽患有血紅蛋白疾病，全球超過 1% 的夫婦面臨風險。

根據世界血友病聯合會 2023 年 10 月發布的一項研究，全球有 830,895 名男性患有血友病，其中約 2,82,266 人患有最嚴重的疾病，且診斷不足。當患者出現血球問題時，早期診斷和治療是維持患者生活品質最有效的方法。

此外，產業主要參與者更加關注血液分析儀的技術優勢將推動這一市場的成長。例如，2022年7月，Sysmex公司宣布推出新的樣本運輸系統模組，可連接到其在血液學領域的旗艦型號XR系列自動血液分析儀（XR系列）。

此外，2022年3月，邁瑞推出了全新BC-700系列，這是一款革命性的血液分析儀系列，融合了全血球計數（CBC）和紅血球沉降速率（ESR）測試。該系列包括兩款開放式樣品瓶型號 BC-700/BC-720 和兩款自動裝載機型號 BC-760/BC-780，旨在為中等容量實驗室提供應用於優質產品的先進診斷技術。

限制

分析儀成本高、耗時且嚴格的監管要求、熟練技術人員的可用性有限以及有限的報銷政策等因素預計將阻礙市場的發展。

They include programmable automated alarm systems for indicating results outside the reference range. Hematology analyzers are concerned with the detection, and monitoring of diseases, prognosis, and subsequent screening and are extensively used against various blood-related diseases such as hemophilia, blood cancer, and blood clots. Other diseases include leukemia, anemia, blood transfusion, malignant lymphomas, and others where hematology diagnosis is used.

The market is driven by factors such as the rise in the prevalence of blood disorders, increasing technological advancements, and rising adoption rates of automated hematology instruments.

Market Dynamics: Drivers

Rise in Prevalence of Blood Disorders

The demand for the global automated hematology analyzer market is driven by multiple factors. One of the primary factors is the increase in the incidence of blood disorders driving the market growth. The Department of Health and Aged Care of the Australian Government reported in December 2022 that there were about 330,000 affected babies born every year, 83% of whom had disorders of sickle cell, 17% had thalassemia, 7% of expectant mothers had hemoglobin disorders, and more than 1% of the couples worldwide were at risk.

According to a World Federation of Hemophilia research study published in October 2023, there were a higher number of 830,895 males worldwide having hemophilia, and about 2,82,266 of these have a severe type of condition that is the most underdiagnosed. Early diagnosis, as well as treatment, are some of the most effective ways to maintain a patient's quality of life when they have a blood cell problem.

Moreover, key players in the industry more focus on the technological advantages of the hematology analyzer would drive this market growth. For instance, in July 2022, Sysmex Corporation announced the launch of new sample transportation system modules that can be connected to the XR-Series Automated Hematology Analyzer (XR-Series), its flagship model in the hematology field.

Also, in March 2022, Mindray launched the new BC-700 Series, a revolutionary hematology analyzer series that incorporates both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests. This series, including two open vial models BC-700/BC-720 and two autoloader models BC-760/BC-780, is designed to empower medium-volume laboratories with advanced diagnostics technologies that are applied in the premium products.

Restraints

Factors such as the high cost of the analyzer, time-consuming & stringent regulatory requirements, limited availability of skilled technicians, and limited reimbursement policies are expected to hamper the market.

Segment Analysis

The global automated hematology analyzer market is segmented based on product & service, type, application, and end-user.

The 3-part hematology analyzer segment accounted for approximately 65.4% of the global automated hematology analyzer market share

The 3-part hematology analyzer segment is expected to hold the largest market share over the forecast period. The 3-part hematology analyzer measures the volume of white blood cells electrically & categorizes blood cells, based on their size, divides into three groups: a small white blood cell group (lymphocytes), a medium-sized white blood cell group (monocytes, eosinophils, and basophils), & large white blood cell group. This test can be used to detect a variety of conditions, such as anemia, infection, and leukemia.

Moreover, key players in the market product launches and introducing innovative technological advancements in the hematology analyzers would drive this segment's growth. For instance, in March 2024, Agappe will launch the most advanced hematology analyzers. AG Innovate will be a customer engagement program where the customers can experience the unveiling of a revolutionary automated 3rd generation hematology analyzer and AE-powered CLIA analyzer.

Similarly, at Medlab Middle East in February 2024, Dymind is also showcasing the DH20 3-part auto hematology analyzer. Compact and user-friendly, the DH20 can measure more clinical parameters using only 9ul sample volume and comes with an optional RF card and barcode function.

Also, in April 2022, Sysmex Europe has recently launched its new three-part differential system 'XQ-320 XQ-Series Automated Hematology Analyzer', answering the needs of this important high-volume market segment. XQ-320 brings excellence in quality to a diverse range of clinical laboratory environments with reliable technology and a new level of usability.

Geographical Analysis

North America accounted for approximately 43.2% of the global automated hematology analyzer market share

North American region is expected to hold the largest market share over the forecast period owing to the increasing burden of blood disorders and the growth in the adoption of hematology analyzers by the major players in this region helps to drive this market growth.

Blood Cancers are one of the driving factors in this region. According to the Leukemia and Lymphoma Society, in 2023, approximately every 3 minutes, one person in the U.S. is diagnosed with leukemia, lymphoma, or myeloma. An estimated combined total of 184,720 people in the U.S. are expected to be diagnosed with leukemia, lymphoma, or myeloma.

Moreover, key players in the industry introducing new product launches and approvals help to drive this market growth. For instance, in August 2023, Abbott received U.S. Food and Drug Administration clearance for its advanced Alinity h-series hematology system, paving the way for laboratories throughout the country to run complete blood counts (CBC) as a part of Abbott's Alinity family of diagnostic products.

Also, in January 2024, HORIBA Medical launched the new HELO 2.0 high throughput automated hematology platform which is CE-IVDR approved, with pending US FDA approval. Following the success of HORIBA Medical's previous HELO, this new generation high-end hematology range has been designed in consultation with customers to further improve and cover all needs of high throughput fully automated hematology.

Market Segmentation

By Product & Service

Instruments
- 3 Part Hematology Analyzer
- 5 Part Hematology Analyzer
- Point-of-care Testing Hematology Analyzers
- Others
Reagents & Consumables
Services

By Type

Fully-Automated Hematology Analyzers
Semi-automated Hematology Analyzers

By Application

Hemorrhagic Conditions
Blood Cancer
Anaemia
Infections
Immune Disorders
Others

By End-user

Hospitals
Clinical Laboratories
Academic and Research Institutes
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the automated hematology analyzer market include Beckman Coulter, Inc., Accurex, Everlife CPC Diagnostics, Sysmex, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Abbott, Horiba Medical, Biobase Biodusty(Shandong), Co., Ltd, Siemens Healthineers and F. Hoffmann-La Roche Ltd among others.

Key Developments

In June 2024, Horiba expanded its line of compact hematology instruments by introducing new models that integrate Erythrocyte Sedimentation Rate (ESR) testing, enhancing diagnostic capabilities with rapid results and comprehensive disease profiling.
In February 2024, Dymind Biotechnology (Shenzhen, China) is introducing its breakthroughs in medical solutions for hematology, coagulation, POCT, immunology, and veterinary at Medlab Middle East 2024, including its new high-end hematology analyzer DH-800 with innovative functions.
In May 2023, Siemens Healthineers launched next-gen hematology analyzers, workflow barriers removed to help patients get results faster. The Atellica HEMA 570 Analyzer and the Atellica HEMA 580 Analyzer. Vital to patient care, the complete blood count (CBC) is among the most performed diagnostic tests in the lab and often provides the first indication of illness in a patient.

Why Purchase the Report?

To visualize the global automated hematology analyzer market segmentation based on product & service, application, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of automated hematology analyzer market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available in Excel consisting of key products of all the major players.

The global automated hematology analyzer report would provide approximately 70 tables, 69 figures, and 182 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product & Service
3.2. Snippet by Type
3.3. Snippet by Application
3.4. Snippet by End-user
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in Prevalence of Blood Disorders
  - 4.1.1.2. Increasing Technological Advancements and Rising Adoption Rates of Automated Hematology Instruments
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of the Analyzer
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product & Service

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Service
- 6.1.2. Market Attractiveness Index, By Product & Service
6.2. Instruments
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. 3-Part Hematology Analyzer
6.4. 5 Part Hematology Analyzer
6.5. Point-of-care Testing Hematology Analyzers
6.6. Others
6.7. Reagents & Consumables
6.8. Services

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Fully Automated Hematology Analyzers
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Semi-Automated Hematology Analyzers

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Hemorrhagic Conditions
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Blood Cancer
8.4. Anaemia
8.5. Infections
8.6. Immune Disorders
8.7. Others

9. By End-user

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 9.1.2. Market Attractiveness Index, By End-user
9.2. Hospitals
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinical Laboratories
9.4. Academic and Research Institutes
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Service
10.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.3.1. U.S.
  - 10.3.3.2. Canada
  - 10.3.3.3. Mexico
10.4. Europe
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Service
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Germany
  - 10.4.7.2. U.K.
  - 10.4.7.3. France
  - 10.4.7.4. Spain
  - 10.4.7.5. Italy
  - 10.4.7.6. Rest of Europe
10.5. South America
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Service
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. Brazil
  - 10.5.7.2. Argentina
  - 10.5.7.3. Rest of South America
10.6. Asia-Pacific
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Service
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.6.7.1. China
  - 10.6.7.2. India
  - 10.6.7.3. Japan
  - 10.6.7.4. South Korea
  - 10.6.7.5. Rest of Asia-Pacific
10.7. Middle East and Africa
- 10.7.1. Introduction
- 10.7.2. Key Region-Specific Dynamics
10.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Service
- 10.8.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.8.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.8.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Beckman Coulter, Inc
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Accurex
12.3. Everlife CPC Diagnostics
12.4. Sysmex
12.5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
12.6. Abbott
12.7. Horiba Medical
12.8. Biobase Biodusty(Shandong), Co., Ltd
12.9. Siemens Healthineers
12.10. F. Hoffmann-La Roche Ltd

LIST NOT EXHAUSTIVE